(Reuters) -Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported on Monday, citing three people familiar with the matter.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shounak Dasgupta)
Comments